Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

DEF-201 active against Western equine encephalitis virus, a potential biothreat

March 17, 2010

Patient enrollment ongoing in phase II trial of pioglitazone in intracerebral hemorrhage

March 17, 2010

Merck & Co. reports clinical data on mometasone furoate/formoterol fumarate in asthma

March 17, 2010

Clinical data on Gardasil reported at EUROGIN meeting

March 17, 2010

Paricalcitol improves albuminuria in diabetic nephropathy

March 16, 2010

Array Biopharma presents new D2 receptor antagonists for allergic disease

March 16, 2010

Cilostazol may benefit patients with acute ischemic stroke

March 16, 2010

Korean scientists identify new dual PPAR-alpha/gamma activator

March 15, 2010

Phase III data on Cervarix for the prevention of HPV-associated cervical cancer disclosed

March 15, 2010

Phase III trial of magnesium sulfate in acute stroke currently recruiting participants

March 15, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...